Managing Potential Side Effects Like any medication, GLP-1s can cause side effects
SCFAs are grouped under the definition of postbiotic, and play a key role in regulating fat metabolism, supporting the function of insulin and reducing inflammation in the gut and beyond
The VA covers GLP-1s mainly for diabetes, with weight-loss access requiring documented medical necessity
Similarly, unfolded protein response (UPR) regulators such as Xbp1, Atf6, Ern1, Hyou1, and Map3k5 were downregulated, reflecting diminished ER stress signaling
Californias Insurance Landscape for GLP-1s California Medicaid, known as Medi-Cal, has expanded GLP-1 coverage in recent years, but coverage for weight loss specifically (as opposed to type 2 diabetes) remains inconsistent